The estimated Net Worth of Christopher C. Puco is at least $10.5 Миллион dollars as of 20 February 2018. Christopher Puco owns over 15,200 units of Align Technology stock worth over $3,466,409 and over the last 12 years Christopher sold ALGN stock worth over $7,056,488.
Christopher has made over 17 trades of the Align Technology stock since 2014, according to the Form 4 filled with the SEC. Most recently Christopher sold 8,764 units of ALGN stock worth $1,993,109 on 30 November 2018.
The largest trade Christopher's ever made was exercising 38,000 units of Align Technology stock on 20 February 2017 worth over $8,555,700. On average, Christopher trades about 9,393 units every 84 days since 2013. As of 20 February 2018 Christopher still owns at least 15,396 units of Align Technology stock.
You can see the complete history of Christopher Puco stock trades at the bottom of the page.
Christopher's mailing address filed with the SEC is C/O ALIGN TECHNOLOGY, INC., 2560 ORCHARD PARKWAY, SAN JOSE, CA, 94131.
Over the last 22 years, insiders at Align Technology have traded over $1,465,859,191 worth of Align Technology stock and bought 2,715,224 units worth $38,925,222 . The most active insiders traders include Brian H Dovey, Kevin T Conroy и Corp /De/ Danaher. On average, Align Technology executives and independent directors trade stock every 11 days with the average trade being worth of $6,502,557. The most recent stock trade was executed by C Raymond Jr Larkin on 15 August 2024, trading 6,500 units of ALGN stock currently worth $1,529,645.
align technology is a global medical device company with industry-leading innovative products -- invisalign clear aligners and itero intraoral scanners -- that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. invisalign system invisalign clear aligners have been used to straighten teeth and treat minor to complex malocclusion for more than 3 million patients worldwide. the invisalign system is a combination of proprietary virtual modeling software and rapid mass-manufacturing processes used to develop a treatment plan and with custom-made aligners for each patient. invisalign is prescribed to patients through invisalign-trained orthodontists and general practitioner dentists (gp) and is offered in over 90 countries. learn more at www.invisalign.com itero intraoral scanner the itero scanner’s parallel confocal imaging technology uses optical and laser scanning to achieve a high level of precisi
Align Technology executives and other stock owners filed with the SEC include: